New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
08:50 EDTLH, LMNXLabCorp announces availability of xTAG CYP2D6 genotype assay
LabCorp (LH) announced the availability of the xTAG CYP2D6 Kit v3 from Luminex (LMNX). The xTAG CYP2D6 Kit v3 is an FDA cleared qualitative genotyping assay that aids clinicians in determining strategies for therapeutics metabolized by the CYP2D6 gene product.
News For LH;LMNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
05:38 EDTLHQuest Diagnostics downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo downgraded Quest Diagnostics (DGX) to its sell-equivalent Underperform rating saying the charges associated with the company's Invigorate savings initiative should not be viewed as one-time by investors. Wells thinks the initiative will need to be ongoing as Quest's margins are declining. It keeps a $60-$65 price target range for shares. The diagnostic testing company closed yesterday up 52c to $71.09. Quest’s main competitor is LabCorp (LH).
January 25, 2015
20:22 EDTLHA small miss for LabCorp could cause a share drop, Barron's says
Subscribe for More Information
January 23, 2015
15:46 EDTLMNXPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
07:32 EDTLHCharles River Labs upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Charles River Labs (CRL) to Outperform citing improving demand for early-stage development services as well as opportunity for share gains due to Covance’s (CVD) pending merger with LabCorp (LH).
January 20, 2015
08:21 EDTLHLabCorp upgraded to Buy from Hold at Evercore ISI
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use